FONTANA, FABRIZIO
FONTANA, FABRIZIO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Editorial: Metabolism in the tumour microenvironment: implications for pathogenesis and therapeutics
2026 A. Rasheed, F. Fontana
Adipocyte-Derived Extracellular Vesicles Endow Melanoma Cells with Stem-like Traits via PGC-1α–Mediated Mitochondrial Reprogramming
2026 G. Giannitti, S. Marchesi, R. Garavaglia, I. Preosto, E. Carollo, P. Sartori, F. Fontana
Mitochondrial bioenergetics and networks in melanoma: an update
2025 G. Giannitti, A.J.J. Paganoni, S. Marchesi, R. Garavaglia, F. Fontana
Exploration of the possible relationships between gut and hypothalamic inflammation and allopregnanolone: preclinical findings in a post-finasteride rat model
2025 S. Diviccaro, R. Oleari, F. Amoruso, F. Fontana, L. Cioffi, G. Chrostek, V. Abenante, J. Troisi, A. Cariboni, S. Giatti, R. Melcangi
Unraveling the role of mitochondrial dynamics in cancer stem cells: Molecular basis and therapeutic implications
2025 G. Giannitti, S. Marchesi, R. Garavaglia, I. Preosto, F. Fontana
Extracellular Vesicles Released From Prostate Cancer Cells Confer Pro‐Tumor Properties to Adipocytes by Stimulating Lipolysis
2025 G. Giannitti, K. Kamińska, S. Marchesi, R. Garavaglia, I. Preosto, M. Grzesiak, F. Fontana
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
2024 F. Fontana, M. Sommariva, M. Anselmi, F. Bianchi, P. Limonta, N. Gagliano
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
2024 F. Fontana, G. Giannitti, S. Marchesi, P. Limonta
The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers
2024 P. Limonta, S. Marchesi, G. Giannitti, L. Casati, F. Fontana
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma
2023 F. Fontana, C. Macchi, M. Anselmi, A.S. Rizzuto, M. Ruscica, P. Limonta
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
2023 F. Fontana, M. Anselmi, P. Limonta
Adipocytes reprogram prostate cancer stem cell machinery
2023 F. Fontana, M. Anselmi, P. Limonta
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy
2022 F. Fontana, M. Anselmi, P. Limonta
Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
2022 F. Fontana, M. Anselmi, P. Limonta
Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression
2022 F. Fontana, M. Anselmi, P. Limonta
Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
2022 M. Anselmi, F. Fontana, M. Marzagalli, N. Gagliano, M. Sommariva, P. Limonta
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model
2022 M. Marzagalli, G. Pelizzoni, A. Fedi, C. Vitale, F. Fontana, S. Bruno, A. Poggi, A. Dondero, M. Aiello, R. Castriconi, C. Bottino, S. Scaglione
Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes
2022 F. Fontana, M. Anselmi, E. Carollo, P. Sartori, P. Procacci, D. Carter, P. Limonta
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
2021 F. Fontana, M. Marzagalli, M. Raimondi, V. Zuco, N. Zaffaroni, P. Limonta
Gene expression profile reveals that APOA-I levels modulate inflammation and lysosomal activity in murine advances atherosclerosis
2021 M. Busnelli, S. Manzini, A. Colombo, F. Fontana, R. Oleari, F. Potì, S. Castiglioni, S. Bellosta, G. Chiesa